NO964684L - 2-(aminometyl)-3,4,7,9-tetrahydro-2H-pyrano-£2,3-e| indol-8-oner og derivater - Google Patents

2-(aminometyl)-3,4,7,9-tetrahydro-2H-pyrano-£2,3-e| indol-8-oner og derivater

Info

Publication number
NO964684L
NO964684L NO964684A NO964684A NO964684L NO 964684 L NO964684 L NO 964684L NO 964684 A NO964684 A NO 964684A NO 964684 A NO964684 A NO 964684A NO 964684 L NO964684 L NO 964684L
Authority
NO
Norway
Prior art keywords
alkyl
pyrano
aminomethyl
indole
tetrahydro
Prior art date
Application number
NO964684A
Other languages
English (en)
Norwegian (no)
Other versions
NO964684D0 (no
Inventor
Gary Paul Stack
Richard Eric Mewshaw
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO964684D0 publication Critical patent/NO964684D0/no
Publication of NO964684L publication Critical patent/NO964684L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO964684A 1995-11-06 1996-11-05 2-(aminometyl)-3,4,7,9-tetrahydro-2H-pyrano-£2,3-e| indol-8-oner og derivater NO964684L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US730795P 1995-11-06 1995-11-06

Publications (2)

Publication Number Publication Date
NO964684D0 NO964684D0 (no) 1996-11-05
NO964684L true NO964684L (no) 1997-05-07

Family

ID=21725405

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964684A NO964684L (no) 1995-11-06 1996-11-05 2-(aminometyl)-3,4,7,9-tetrahydro-2H-pyrano-£2,3-e| indol-8-oner og derivater

Country Status (22)

Country Link
EP (1) EP0771801B1 (de)
JP (1) JPH09169764A (de)
KR (1) KR970027086A (de)
CN (1) CN1083843C (de)
AR (1) AR004523A1 (de)
AT (1) ATE177102T1 (de)
AU (1) AU701636B2 (de)
BR (1) BR9605437B1 (de)
CA (1) CA2189525C (de)
CZ (1) CZ286649B6 (de)
DE (1) DE69601611T2 (de)
DK (1) DK0771801T3 (de)
ES (1) ES2128145T3 (de)
GR (1) GR3030132T3 (de)
HU (1) HUP9603058A3 (de)
IL (1) IL119483A (de)
MX (1) MX9605369A (de)
NO (1) NO964684L (de)
NZ (1) NZ299680A (de)
SK (1) SK281085B6 (de)
TW (1) TW467914B (de)
ZA (1) ZA969191B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT923576E (pt) * 1996-08-27 2003-02-28 Wyeth Corp Derivados de 4-amino-etoxi-indolona como agonistas de dopamina d2
JP2001502327A (ja) * 1996-10-15 2001-02-20 アメリカン・ホーム・プロダクツ・コーポレイション ２，３，８，９―テトラヒドロ―７Ｈ―１，４―ジオキシノ［２，３―ｅ］インドール―８―オンのアザヘテロサイクリルメチル誘導体
CN1138761C (zh) * 1997-02-18 2004-02-18 惠氏公司 4－氨基烷氧基－1,3－二氢苯并咪唑－2－酮衍生物、它们的制备方法以及它们作为多巴胺自身受体（d2）激动剂的用途
US5990144A (en) * 1997-02-18 1999-11-23 American Home Products Corporation 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autoreceptor agonists
US6541502B1 (en) 2001-07-20 2003-04-01 Wyeth 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
US6541501B2 (en) * 2001-07-20 2003-04-01 Wyeth 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
TW200811182A (en) 2006-05-25 2008-03-01 Wyeth Corp Oxindoledioxans, synthesis thereof, and intermediates thereto

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314944A (en) 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
DE4135474A1 (de) 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
DE4140540A1 (de) 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane
EP1123933A1 (de) * 1994-10-14 2001-08-16 MERCK PATENT GmbH ZNS wirksames 2-[5-(4-Fluorphenyl)-3-pyridylmethylaminomethyl]chroman

Also Published As

Publication number Publication date
AR004523A1 (es) 1998-12-16
SK141396A3 (en) 1997-05-07
SK281085B6 (sk) 2000-11-07
ES2128145T3 (es) 1999-05-01
HK1010104A1 (en) 1999-06-11
ZA969191B (en) 1998-04-30
HUP9603058A2 (en) 1997-05-28
CA2189525A1 (en) 1997-05-07
BR9605437B1 (pt) 2009-08-11
GR3030132T3 (en) 1999-07-30
DE69601611D1 (de) 1999-04-08
MX9605369A (es) 1997-05-31
HUP9603058A3 (en) 1998-12-28
HU9603058D0 (en) 1996-12-30
AU7055496A (en) 1997-05-15
KR970027086A (ko) 1997-06-24
CN1151989A (zh) 1997-06-18
EP0771801B1 (de) 1999-03-03
CN1083843C (zh) 2002-05-01
AU701636B2 (en) 1999-02-04
CZ286649B6 (cs) 2000-05-17
CA2189525C (en) 2006-04-25
IL119483A (en) 1999-06-20
TW467914B (en) 2001-12-11
EP0771801A1 (de) 1997-05-07
NO964684D0 (no) 1996-11-05
DK0771801T3 (da) 1999-09-27
JPH09169764A (ja) 1997-06-30
NZ299680A (en) 1998-05-27
CZ324096A3 (en) 1997-12-17
ATE177102T1 (de) 1999-03-15
DE69601611T2 (de) 1999-10-21
BR9605437A (pt) 1998-08-04
IL119483A0 (en) 1997-01-10

Similar Documents

Publication Publication Date Title
YU51400A (sh) Derivati 2-piridilmetilamina, kao korisni fungicidi
GB2392154B (en) Protein Kinase Inhibitors
SE8503922L (sv) Analgetiska 1,2-bensisotiazol-3-ylpiperazin-derivat
IL165262A0 (en) Kinase inhibitors
TW336939B (en) Lipopeptide derivatives, a process for their preparation and their use
MX9801129A (es) Agentes farmaceuticos.
AU2605784A (en) N-aromatic-n:-cycloalkylalkanoyl-piperazines
DK0862562T3 (da) Benzoxazepinforbindelser, fremstilling deraf og anvendelse deraf som lipidniveauformindskende midler
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
EA199800170A1 (ru) Производные 2-(4-замещенного)бензиламино-2-метилпропанамида
NO964684L (no) 2-(aminometyl)-3,4,7,9-tetrahydro-2H-pyrano-£2,3-e| indol-8-oner og derivater
NO20001198L (no) Pyrrolopyrrolondervater som inhibitorer av nøytrofil elastase
NO982927L (no) Biologisk aktive benzotiazolon etanaminer
EP0251574A3 (de) Abkömmlinge von N-(6,6-Dimethyl-2-hepten-4-ynyl)-1-naphthalenmethanamin mit Wirkung gegen Pilze und Verfahren zu deren Anwendung
GB9420747D0 (en) 1,5 benzodiazepine derivatives
NO973242L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti
ATE216883T1 (de) Verwendung von 4-phenyl-3,6-dihydro-2h-pyridyl derivaten als nmda rezeptor subtyp blocker
NO944577L (no) Hemming av effekten av amyloidogene proteiner
FI915653A0 (fi) 5-amino-5,6,7,8-tetrahydroquinoliner och beslaektade foereningar, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
AU2160199A (en) New developer combinations for oxidation colouring agents
IT1269584B (it) Procedimento per la preparazione di derivati di 5,6-diidrossi- 2-ammino-1,2,3,4- tetraidronaftalene
TW358809B (en) Phenylamidinothiophene compound and anti-inflammatory agent containing the same
TW355184B (en) Substituted thiophenylsulfonylureas and -thioureas, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
MX9704548A (es) Compuestos peptidomesticos antiherpes.
NO944912L (no) Fremgangsmåte for å öke makrofagfunksjonen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application